A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh

Journal of Occupational and Environmental Medicine

Volumn 56, Issue 6, 2014, Pages 652-658

  Harper, Kristin N ^a   Liu, Xinhua ^a   Hall, Megan N ^a   Ilievski, Vesna ^a   Oka, Julie ^a   Calancie, Larissa ^a   Slavkovich, Vesna ^a   Levy, Diane ^a   Siddique, Abu ^b   Alam, Shafiul ^b   Mey, Jacob L ^c,d   Van Geen, Alexander ^c   Graziano, Joseph H ^a   Gamble, Mary V ^a  

^a Department of Medicine   (United States)

^b Department of Biostatistics Mailman School of Public Health Columbia University ^*  (Bangladesh)

^c International Research Institute for Climate and Society   (United States)

^d Kingsbridge Community College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ARSENIC; BIOLOGICAL MARKER; CARBONYL DERIVATIVE; DRINKING WATER; PLASMA PROTEIN; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE;

ADULT; AGED; ARTICLE; BANGLADESH; DOSE RESPONSE; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; ANALOGS AND DERIVATIVES; ENVIRONMENTAL EXPOSURE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROTEIN CARBONYLATION; WATER POLLUTION;

ADULT; ARSENIC; BANGLADESH; DEOXYGUANOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN CARBONYLATION; WATER POLLUTION, CHEMICAL;

EID: 84902259392     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000166     Document Type: Article

References (81)

1. Chen C, Chuang Y, Lin T, Wu S. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high arsenic artesian well water and cancers. Cancer Res. 1985;45:5895-5899.
2. Chiou H, Huang W, Su C, Chang S, Hsu Y, Chen C. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997;28:1717-1723.
3. Chen C, Chiou H, Chiang M, Lin L, Tai T. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol. 1996;16:504-510.
4. Navas-Acien A, Sharrett A, Silbergeld E, et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol. 2005;162:1037-1049.
5. Chen Y, Graziano J, Parvez F, et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ. 2011;342:d2431.
6. Navas-Acien A, Silbergeld E, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. J Am Med Assoc. 2008;300:814-822.
7. Navas-Acien A, Silbergeld E, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006. Epidemiology. 2009;20:816-820.
8. Del Razo L, Garćia-Vargas G, Valenzuela O, et al. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a crosssectional study in the Zimaṕan and Lagunera regions in Mexico. Environ Health. 2011;10:73.
9. Steinmaus C, Yuan Y, Liaw J, Smith A. Low-level population exposure to inorganic arsenic in the United States and diabetes mellitus: a reanalysis. Epidemiology. 2009;20:807-815.
10. Chen Y, Ahsan H, Slavkovich V, et al. No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ Health Perspect. 2010;118:1299-1305.
11. Smith A, Lingas E, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78:1093-1103.
12. Kitchin K, Ahmad S. Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol Lett. 2003;137:3-13.
13. Andrew A, Burgess J, Meza M, et al. Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Environ Health Perspect. 2006;114:1193-1198.
14. Hamadeh H, Trouba K, Amin R, Afshari C, Germolec D. Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol Sci. 2002;69:306-316.
15. Davis C, Uthus E, Finley J. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr. 2000;130:2903-2909.
16. Pilsner J, Liu X, Ahsan H, et al. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr. 2007;86:1179-1186.
17. Ren X, McHale C, Skibola C, Smith A, Smith M, Zhang L. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect. 2011;119:11-19.
18. Petrick J, Jagadish B, Mash E, Aposhian H. Monomethylarsonous acid (MMAIII) and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem Res Toxicol. 2001;14:651-656.
19. Davey J, Bodwell J, Gosse J, Hamilton J. Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicol Sci. 2007;98:75-86.
20. Davey J, Nomikos A, Wungjiranirun M, et al. Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor-and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis. Environ Health Perspect. 2008;116:165-172.
21. Sciandrello G, Caradonna F, Mauro M, Barbata G. Arsenic-induced DNA hypermethylation affects chromosomal instability in mammalian cells. Carcinogenesis. 2004;25:413-417.
22. Moore L, Smith A, Eng C, et al. Arsenic-related chromosomal alterations in bladder cancer. N Natl Cancer Inst. 2002;94:1688-1696.
23. Chou W, HawkinsA, Barrett J, Griffin C, DangD. Arsenic inhibition of telomerase transcription leads to genetic instability. J Clin Invest. 2001;108:1541-1547.
24. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995;358:1-3.
25. Valko M, Rhodes C, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1-40.
26. Dhalla N, Temsah R, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000;18:655-673.
27. Hoeschen R. Oxidative stress and cardiovascular disease. Can J Cardiol. 1997;13:1021-1025.
28. West I. Radicals and oxidative stress in diabetes. Diabet Med. 2000;17:171-180.
29. Kessel M, Liu S, Xu A, Santella R, Hei T. Arsenic induces oxidative DNA damage in mammalian cells. Mol Cell Biochem. 2002;234/235: 301-308.
30. Li M, Cai J, Chiu J. Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells. J Cell Biochem. 2002;87:29-38.
31. Ruiz-Ramos R, Lopez-Carrillo L, Rios-Perez A, Vizcaya-Rúiz AD, Cebrian M. Sodium arsenite induces ROS generation, DNA oxidative damage, HO-1 and c-MYC proteins, NF-kB activation and cell proliferation in human breast cancer MCF-7 cells. Mutat Res. 2009;674:109-115.
32. Flora S. Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2, 3-dimercaptosuccinic acid in rats. Clin Exp Pharmacol Physiol. 1999;26:865-869.
33. Wei M, Wanibuchi H, Morimura K, et al. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis. 2002;23:1387-1397.
34. Yamanaka K, Takabayashi F, Mizoi M, An Y, Hasegawa A, Okada S. Oral exposure of dimethylarsenic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-oxo-2-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Biochem Biophys Res Commun. 2001;287:66-70.
35. Engstr̈om K, Vahter M, Johansson G, et al. Chronic exposure to cadmium and arsenic strongly influences concentrations of 8-oxo-7, 9-dihydro-2-deoxyguanosine in urine. Free Radic Biol Med. 2010;48:1211-1217.
36. Burgess J, Meza M, Josyula A, et al. Environmental arsenic exposure and urinary 8-OHdG in Arizona and Sonora. Clin Toxicol. 2007;45:490-498.
37. Engstr̈om K, Vahter M, Lindh C, et al. Low 8-oxo-7, 8-dihydro-2-deoxyguanosine levels and influence of genetic background in an Andean population exposed to high levels of arsenic. Mutat Res. 2010;683:98-105.
38. Hall M, NiedzwieckiM, Harper K, et al. Association between chronic arsenic exposure and blood glutathione and glutathione disulfide concentration in Bangladeshi adults. Environ Health Perspect. 2013;121:1068-1074.
39. Ahsan H, Chen Y, Parvez F, et al. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol. 2006;16:191-205.
40. Cheng Z, Zheng Y, Mortlock R, Van Geen A. Rapidmulti-element analysis of groundwater by high-resolution inductively coupled plasma mass spectrometry. Anal Bioanal Chem. 2004;379:512-518.
41. Van Geen A, Cheng Z, Seddique AA, et al. Reliability of a commercial kit to test groundwater for arsenic in Bangladesh. Environ Sci Technol. 2005;39:299-303.
42. van Geen A, Cheng Z, Jia Q, et al. Monitoring 51 community wells in Araihazar, Bangladesh, for up to 5 years: implications for arsenic mitigation. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2007;42:1729-1740.
43. Stroh A. Determination of Pb and Cd in whole blood using isotope dilution ICP-MS. Atom Spectrosc. 1993;37:1575-1579.
44. Pruszkowski E, Neubauer K, Thomas R. An overview of clinical applications by inductively coupled plasma mass spectrometry. Atom Spectrosc. 1998;19:111-115.
45. Nixon D, MussmannG, Eckdahl S, Moyer T. Total arsenic in urine: palladiumpersulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry. Clin Chem. 1991;37:1575-1579.
46. Heitkemper D, Vela N, Stewart K, Westphal C. Determination of total and speciated arsenic in rice by ion chromatography and inductively coupled plasma mass spectrometry. J Anal At Spectrom. 2001;16:299-306.
47. Winterbourn C, Buss I. Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol. 1999;300:106-111.
48. Zipprich J, Terry M, Liao Y, et al. Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Cancer Res. 2009;69:2966-2972.
49. Cone E, Caplan Y, Moser F, Robert T, Shelby M. Normalization of urinary drug concentrations with specific gravity and creatinine. J Anal Toxicol. 2009;33:1-7.
50. Loft S, Larsen P, Rasmussen A, et al. Oxidative DNA damage after transplantation of the liver and small intestine in pigs. Transplantation. 1995;59:16-20.
51. Griffiths H. The influence of diet on protein oxidation. Nutr Res Rev. 2002;15:3-17.
52. Drury J, Jeffers G, Cooke R. Urinary 8-hydroxydeoxyguanosine in infants and children. Free Radic Res. 1998;28:423-428.
53. England T, Beatty E, Rehman A, et al. The steady-state levels of oxidative DNA damage and of lipid peroxidation (F2-isoprostanes) are not correlated in healthy human subjects. Free Radic Res. 2000;32:355-362.
54. Pi J, Yamauchi H, Kumagai Y, et al. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ Health Perspect. 2002;110:331-336.
55. Wu M, Chiou H, Wang T, et al. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ Health Perspect. 2001;109:1011-1017.
56. Yamauchi H, Aminaka Y, Yoshida K, Sun G, Pi J, Waalkes M. Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol Appl Pharmacol. 2004;198:291-296.
57. Soignet S, Maslak P, Wang Z, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New Eng J Med. 1998;339:1341-1348.
58. Olinski R, Rozalksi R, Gackowski D, Foksinski M, Siomek A, Cooke M. Urinary measurement of 8-oxodg, 8-oxogua, and 5HMUra: a noninvasive assessment of oxidative damage to DNA. Antioxid Redox Signal. 2006;8:1011-1019.
59. Kile M, Houseman E, Breton C, et al. Dietary arsenic exposure in Bangladesh. Environ Health Perspect. 2007;115:889-893.
60. Prieḿe H, Loft S, Klarlund M, Grønbaek K, Tønnesen P, Poulsen H. Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7, 8-dihydro-2-deoxyguanosine excretion. Carcinogenesis. 1998;19:347-351.
61. Loft S, Vistisen K, Ewertz M, Tjønneland A, Overvad K, Poulsen H. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis. 1992;13:2241-2247.
62. Marangon K, Devaraj S, Jialal I. Measurement of protein carbonyls in plasma of smokers and in oxidized LDL by an ELISA. Clin Chem. 1999;45:577-578.
63. Wu H, Wang Q, Wang L, et al. Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis. 2007;28:995-999.
64. NilssonR, NordlinderR, TagessonC, Walles S, J̈arvholmB. Genotoxic effects in workers exposed to low levels of benzene from gasoline. Am J Ind Med. 1996;30:317-324.
65. Singh R, Kaur B, Kalina I, et al. Effects of environmental air pollution on endogenous oxidative DNA damage in humans. Mutat Res. 2007;620:71-82.
66. Wu L, Chiou C, Chang P, Wu J. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339:1-9.
67. Honda M, Yamada Y, Tomonaga M, Ichinose H, Kamihira S. Correlation of urinary 8-hydroxy-2-deoxyguanosine (8-OHdG), a biomarker of oxidative DNA damage, and clinical features of hematological disorders: a pilot study. Leuk Res. 2000;24:461-468.
68. Rossner P, Terry M, Gammon M, et al. Plasma protein carbonyl levels and breast cancer risk. J Cell MolMed. 2007;11:1138-1148.
69. Svecova V, Rossner P, Dostal M, Topinka J, Solansky I, Sram R. Urinary 8-oxodeoxyguanosine levels in children exposed to air pollutants. Mutat Res. 2009;662:37-43.
70. Chuang K, Chan C, Su T, Lee C, Tang C. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med. 2007;176:370-376.
71. Garibaldi S, Aragno I, Odetti P, Marinari U. Relationships between protein carbonyls, retinol and tocopherols level in human plasma. Biochem Mol Biol Int. 1994;34:729-736.
72. Garibaldi S, Valentini S, Aragno I, Pronzato M, Tavers N, Odetti P. Plasma protein oxidation and antioxidant defense during aging. Int J Vitam Nutr Res. 2001;71:332-338.
73. Poulsen H, Loft S, Prieme H, et al. Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S- transferase activity and urinary creatinine excretion. Free Radic Res. 1998;29:565-571.
74. Bloomer R, Fisher-Wellman K. Blood oxidative stress biomarkers: influence of sex, exercise training status, and dietary intake. Gend Med. 2008;5:218-228.
75. Pilger A, Germadnik D, Riedel K, Meger-Kossien I, Scherer G, R̈udiger H. Longitudinal study of urinary 8-hydroxy-2-deoxyguanosine excretion in healthy adults. Free Radic Res. 2001;35:273-280.
76. Coppin J, Qu W, Waalkes M. Interplay between cellular methyl metabolism and adaptive efflux during oncogenic transformation from chronic arsenic exposure in human cells. J Biol Chem. 2008;283:19342-19350.
77. Vahter M. Species differences in the metabolism of arsenic compounds. App Organomet Chem. 1994;8:175-182.
78. Basu A, Mahata J, Gupta S, GiriA. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res. 2001;488:171-194.
79. Drobńa Z, Walton F, Harmon A, Thomas D, Styblo M. Interspecies differences in metabolism or arsenic by cultured primary hepatocytes. Toxicol Appl Pharmacol. 2010;245:47-56.
80. NiedzwieckiM, HallM, Liu X, et al. Blood glutathione redox status and global methylation of peripheral blood mononuclear cellDNAin Bangladeshi adults. Epigenetics. 2013;8:7.
81. Allen R, Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med. 2000;28:463-499.